At its meeting on February 22, 2022, Sanofi’s Board of Directors has decided to propose, on the occasion of its next General Shareholder Meeting to be held on May 3, 2022, the renewal of the mandates of Paul Hudson, Christophe Babule, Patrick Kron and Gilles Schnepp and the appointment of Carole Ferrand, Emile Voest and Antoine Yver as independent Directors. Melanie Lee and Carole Piwnica will leave the Board of Directors.
Investegate announcements from Sanofi - Aventis Groupe, Sanofi’s Board of Directors proposes the appointment of Carole Ferrand, Emile Voest and Antoine Yver as independent Directors
Caliber Associates Recruits Chief Development Officer for Coherus BioSciences huntscanlon.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from huntscanlon.com Daily Mail and Mail on Sunday newspapers.